X
    學術可視化工作室RC   登錄   提交文稿
學術英文編修

Journal of Inflammation Research

期刊標題檢索 J INFLAMM RES 最新評論: Submission deadline is January 24th, minor revisions due in May, and ... (2024-05-22)


期刊名稱:   ISSN:   主題領域:   影響因子範圍: -
索引:   類別:   開放訪問:   排序方式:

[Journal of Inflammation Research]您好,您是該頁面的第 74002 位訪客。

期刊簡介
期刊名稱Journal of Inflammation Research Journal of Inflammation Research
LetPub Score
7.5
54 ratings
Rate

Reputation
8.2

Influence
6.4

Speed
9.3

期刊簡稱J INFLAMM RES
ISSN1178-7031
h-indexN.A.
CiteScore
CiteScoreSJRSNIPCiteScore Rank
6.101.0470.886
Subject fieldQuartilesRankPercentile
Category: Medicine
Subcategory: Immunology and Allergy
Q2100 / 233
Category: Medicine
Subcategory: Immunology
Q2118 / 236

自引率 (2023-2024)2.40%自引率趨勢
掲載範囲
An international, peer-reviewed, open access, online journal that welcomes laboratory and clinical findings on the molecular basis, cell biology and pharmacology of inflammation.
官方網站http://www.dovepress.com/journal-of-inflammation-research-journal
在線稿件提交
開放訪問Yes
出版商Dove Medical Press
主題領域Immunology and Microbiology
出版國/地區NEW ZEALAND
發行頻率
創刊年0
每年文章數449每年文章數趨勢
黃金OA百分比98.26%
OA Related Info
APC: Yes( USD3300; )
APC waiver:Check Notes
Other charges: No
Keywords: inflammation、anti-inflammatory drugs
Useful LinksAims & ScopeAuthor InstructionsEditorial BoardAnonymous peer review
Web of Science 四分位
2023-2024
WOS Quartile: Q2

CategoryEditionJIF QuartileJIF RankingJIF Percentage
IMMUNOLOGYSCIEQ273/181
索引 (SCI or SCIE)Science Citation Index Expanded
鏈接到PubMed Central (PMC)https://www.ncbi.nlm.nih.gov/nlmcatalog?term=1178-7031%5BISSN%5D
平均審稿時間 *來自出版商的數據:
來自作者的數據: 16 Weeks
競爭力 *來自作者的數據:
參考鏈接
相關期刊 【Journal of Inflammation Research】CiteScore趨勢
自引率趨勢 每年文章數趨勢
作者評論
*所有的審稿過程指標,如接受率和審稿速度,僅限於用戶提交的稿件。因此,這些指標可能無法準確反映期刊的競爭力或速度。
  • 同一學科的期刊
  • CiteScore趨勢
  • 自引率趨勢
  • 每年文章數趨勢
  •  
    學科內的可信期刊 影響因子
    Science ImmunologyH-index: 0

    CiteScore: 32.90
    Journal of Allergy and Clinical Immunology-In PracticeH-index: 40

    CiteScore: 11.10
    Cancer Immunology ResearchH-index: 62

    CiteScore: 15.60
    npj VaccinesH-index: 8

    CiteScore: 11.90
    OncoImmunologyH-index: 58

    CiteScore: 12.80
    OncoImmunologyH-index: 49

    CiteScore: 12.80
    ALLERGOLOGY INTERNATIONALH-index: 45

    CiteScore: 12.60
    HLAH-index: 93

    CiteScore: 3.00
    Immunity & AgeingH-index: 38

    CiteScore: 10.20
    Clinical and Translational AllergyH-index: 28

    CiteScore: 7.50
    學科內最受檢索的期刊 頁面查看次數
    Cancer Immunology Research57106
    OncoImmunology54803
    OncoImmunology50218
    Science Immunology39870
    npj Vaccines29223
    Human Vaccines & Immunotherapeutics24480
    Human Vaccines & Immunotherapeutics24446
    Endocrine Metabolic & Immune Disorders-Drug Targets20780
    Journal of Allergy and Clinical Immunology-In Practice18703
    Allergy Asthma & Immunology Research18484
  •  

    Journal of Inflammation Research Journal of Inflammation Research
    明年預測:
    穩步上升 無變化 逐步下降  刷新
  •  

     
  •  

     


首頁    上一頁    1    下一頁    末頁  (頁
/1)
  [Journal of Inflammation Research] 的評論撰寫評論
作者: PPTTPXY


領域: 医学
審稿時間: 4.0 month(s)
結果: 修改後接受


撰寫評論

2024-05-22 16:12:11 評論於
Submission deadline is January 24th, minor revisions due in May, and final acceptance by the end of May.
Digestive-related multicenter clinical studies can be frustrating to submit. Winning feels like a relief, but then you might also feel a bit of loss
(0) 讚! | PPTTPXY

作者: jinhui


領域: 医学
審稿時間: 1.0 month(s)
結果: 待定&不明


撰寫評論

2024-05-17 00:53:25 評論於
It has been 13 days and I am still in 1a evaluation. How many more days until I can get the result?
(0) 讚! | jinhui

作者: 数到三


領域: 医学
審稿時間: 4.0 month(s)
結果: 直接被接受


撰寫評論

2024-05-14 23:04:08 評論於
The review process is not as fast as before, I submitted on 11.6 and received on 3.5. The second paper of the research group has been in the 1a stage for two weeks now. Bioinformatics articles without experiments are basically rejected directly
(0) 讚! | 数到三

作者: 爱听摇滚的哪吒


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2024-03-05 17:04:23 評論於
Is there experimental verification for the bioinformatics you wrote?
(0) 讚! | 爱听摇滚的哪吒

作者: Dentist Liu


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2024-02-29 13:50:06 評論於
How long does the first phase last?
(0) 讚! | Dentist Liu

作者: ILOVER1994


領域: 医学
審稿時間: 3.0 month(s)
結果: 修改後接受


撰寫評論

2024-01-25 08:38:58 評論於
One paper has been published, and one paper has been accepted. The overall submission experience was good, with quick processing and responsible editors. The submission system was also quite user-friendly
(0) 讚! | ILOVER1994

作者: hanxy


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2023-08-17 09:11:21 評論於
There are many things to deal with before submission, the editor requested to revise, provide complete WB bands, ethical approval, etc. Has not been submitted for external review yet
(0) 讚! | hanxy

作者: hhhgf


領域: 医学
審稿時間: 1.0 month(s)
結果: 修改後接受


撰寫評論

2021-12-15 12:47:38 評論於
Infection-related, Bioinformatics + Basic, extremely fast review process, submission to publication cycle of 2 months.
(0) 讚! | hhhgf

作者: humour


領域: 医学
審稿時間: 3.0 month(s)
結果: 待定&不明


撰寫評論

2021-06-06 01:43:45 評論於
Do we need all three repetitions of the data?
(0) 讚! | humour

作者: yydlt


領域: 医学
審稿時間: 4.0 month(s)
結果: 修改後接受


撰寫評論

2021-06-03 13:24:15 評論於
The article requires raw data as well as WB original uncut film strips, so let's prepare all the raw data before starting the submission!
(0) 讚! | yydlt

作者: 谢大头


領域: 医学
審稿時間: 1.0 month(s)
結果: 修改後接受


撰寫評論

2021-02-28 17:55:01 評論於
Hit it with one shot, but there is a lot of data in the article itself, a total of 19 figures, running through 30 paragraphs and many other data. The magazine is fast, and the key to success lies in the editor, while the reviewers are of secondary importance. They have a high requirement for the innovative aspect of the article and need to clearly state where the innovation lies.
(0) 讚! | 谢大头

首頁    上一頁    1    下一頁    末頁  (頁
/1)

開始撰寫 [Journal of Inflammation Research] 的評論:





Contact us

Contact us  

Your name*

Your email*

Your message*

Please fill in all fields and provide a valid email.

Security Code*